CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is ...

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB : CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company developing novel ...

WASHINGTON — Corona Cero last year became the first beer sponsor for the Olympics at the worldwide level. But the brand, which is marketed by Anheuser-Busch InBev globally but Grupo Modelo in the U.S.

Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC ...

Cero Generation and Enso Energy aim to build a 1GW solar and storage portfolio in the UK, such as the operational Larks Green project, pictured above. Image: Cero Generation Independent power producer ...

In the USA-Mexico rivalry, there's a scoreline that sends one fanbase into elation while irking the other. Whether it's in a high-stakes World Cup game or in a "friendly" match against El Tri, you’ll ...

CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236. What Happened: ...

Whether it was in AAA, CMLL, Lucha Underground, the independent scene, TNA, AEW, or now WWE, there's always been one constant about Penta's career; "Cero Miedo". It's connected to him in a way that ...

CERo Therapeutics (NASDAQ:CERO) will implement a 1-for-20 reverse stock split on June 13, 2025. The split reduces outstanding common shares from ~10.32M to ~516,092. The stock will begin trading on a ...

CERo Therapeutics Holdings, Inc. has announced the issuance of additional shares of its Series D Preferred Stock to institutional investors, following a previous agreement worth up to $8 million. This ...

CERo’s CEO, Chris Ehrlich, emphasized the significance of the trial and the involvement of prestigious medical centers. In addition, CERo Therapeutics has regained compliance with Nasdaq’s minimum ...